Developer docs
API playgroundTry for free, no card

Search company profiles

Trialzen

Full company profile

uuid02i3fct

Namestring
Trialzen
Legal namestring
Trialzen SA
Websiteurl
trialzen.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Trialzen SA is a Belgian private SaaS company founded in 2021 by former n-Side executives Cédric Druck (CEO/CTO), Bruno Coppé (Chairman) and Yves Pochet (Scientific Adviser), headquartered in Lasne, Belgium. It develops the Trialzen Forecast & Planning Solution (FPS), a cloud-based software platform for clinical trial supply chain forecasting, scenario modeling and optimization aimed at pharmaceutical sponsors running global clinical trials, with particular emphasis on oncology and advanced therapy trials. The product combines mathematical optimization, stochastic (Monte Carlo) modeling, real-time RTSM/IRT integration, AI-powered automated release plan generation, and a standard API for enterprise dashboards. Its core value proposition addresses the well-documented industry problem that approximately 50% of manufactured clinical trial drug supply is never administered to patients, with the company citing documented client outcomes of 50x ROI, a 20% reduction in site shipments, and per-study savings exceeding $1 million.

Trialzen operates an enterprise sales-led go-to-market with an all-inclusive annual subscription pricing model (no per-feature fees), supplemented by demo and sandbox environments and active participation in industry events such as GCSG, CSForum, COGEurope and CSDG. Distribution is delivered through direct sales to pharmaceutical sponsors and a partner network of CROs, CMOs and supply chain consultants; in April 2026 Trialzen announced a strategic alliance with Perceptive eClinical to launch Perceptive Clinical Intelligence, embedding its forecasting and simulation engine into Perceptive's Clinphone Pro IRT platform. The company maintains ISO 27001-aligned security controls and GDPR compliance, and has shipped four major platform releases since its v1.0.0 launch in April 2024, most recently v1.8.0 in February 2026. No external venture funding rounds, institutional investors, or parent company ownership signals are disclosed in the available sources.

Short descriptiontext

Trialzen is a Belgian SaaS company that develops the Forecast & Planning Solution (FPS), a cloud platform for clinical trial supply chain forecasting, scenario modeling and RTSM/IRT integration, sold via all-inclusive annual subscriptions to pharmaceutical sponsors and delivered through CRO/CMO partners and a Perceptive eClinical alliance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBrussels, Belgium
HQ citystring
Brussels
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial forecasting, supply chain optimization, clinical supply planning, RTSM integration software, pharmaceutical supply software
Industry1 code
PRIMARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Computer Systems Design Services541512
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Supply Chain Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Subscription - Forecast & Planning Solution (FPS)
TypeSubscription Recurring
Description

Software-as-a-service subscription model offering access to Trialzen's forecasting and planning capabilities. All-inclusive pricing model with no per-feature fees. Customers can access demos and sandbox environments before purchase.

trialzen.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1All-inclusive SaaS subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Simple, all-inclusive pricing - use all capabilities without per-feature fees. No specific price points disclosed publicly.

trialzen.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Trialzen develops and sells a SaaS platform, the Forecast & Planning Solution (FPS), that enables pharmaceutical sponsors to forecast, plan, and optimize the supply chain for clinical trials. The platform uses stochastic modeling and mathematical optimization to reduce clinical drug waste, optimize RTSM/IRT parameters, and run scenario simulations across complex protocol designs including adaptive trials and oncology studies. Customers access the platform via annual all-inclusive subscriptions and can also engage joint consultancy services through the Perceptive Clinical Intelligence alliance with Perceptive eClinical.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50x ROI (5,000%) for clients
+3 more records
Product overview1 text field

Trialzen offers a unified product portfolio centered on its Forecast & Planning Solution (FPS), a SaaS platform for clinical trial supply chain management. The core FPS product provides end-to-end forecasting, planning, and optimization capabilities including real-time RTSM/IRT integration, scenario modeling, and automated release planning. Through the Perceptive Clinical Intelligence alliance, Trialzen's simulation engine is embedded within Perceptive eClinical's Clinphone Pro platform to deliver integrated consultancy services spanning the entire clinical trial lifecycle from early supply planning through mid-study forecast adjustments.

Product and service2 records
1Trialzen FPS (Forecast & Planning Solution)
CategoryClinical trial supply chain forecasting software
Description

SaaS platform providing clinical trial supply chain forecasting, planning, and optimization for pharmaceutical sponsors. Enables design of forecasting models per protocol specifications, optimization of supply budgets, alignment of supply chain with trial schedules, and minimization of overage and waste through predictive analytics, scenario modeling, RTSM/IRT integration, and AI-powered automated release planning.

2Perceptive Clinical Intelligence
CategoryClinical supply chain consulting and integrated services
Description

Technology-enabled clinical supply consultancy service combining Perceptive eClinical's randomization and clinical supply expertise with Trialzen's forecasting and simulation engine, integrated into Perceptive's Clinphone Pro IRT platform. Lets sponsors execute integrated supply planning across the full clinical trial lifecycle, from early supply planning through mid-study forecast adjustments.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-27
Description

Strategic alliance to launch 'Perceptive Clinical Intelligence' - a technology-enabled clinical supply consultancy service. Combines Perceptive's 30 years of clinical supply expertise and Clinphone Pro IRT platform with Trialzen's advanced forecasting and simulation technologies. Enables sponsors to move from scenario planning to operational action in a single integrated environment. Engagements reportedly generate savings exceeding $1 million per study.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Content partnership with COGEurope (The PBC Group). Trialzen serves as a content partner for the annual conference, with Cedric Druck presenting and company having visibility at the event.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Partner network of contract research organizations, contract manufacturing organizations, and supply chain management consultants who provide expert guidance to sponsors using Trialzen's software.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Clario (formed from the merger of Bioclinica and ERT) delivers clinical trial endpoint technology, imaging, and RTSM/supply chain solutions. It overlaps with Trialzen in clinical supply and trial technology for pharma sponsors and CROs.

TypeBroad incumbent
Description

Oracle's Clinical One platform offers randomization, supply management, and trial operations as part of a broad life sciences cloud suite. As a large incumbent, it represents a competitive threat via bundling and an integration partner for Trialzen's complementary forecasting layer.

TypeBroad incumbent
Description

Veeva Vault CTMS and Vault EDC are enterprise clinical trial platforms used by most large pharma sponsors. While not a pure-play in supply forecasting, Veeva's broad installed base and clinical operations suite make it a key incumbent that could bundle or compete with Trialzen's specialized supply planning.

TypeDirect peer
Description

Signant Health is a clinical trial technology provider offering RTSM/IRT, patient-centric tools, and clinical supply solutions. It directly overlaps with Trialzen's supply forecasting and RTSM integration value proposition and serves the same pharma sponsor customer base.

TypeDirect peer
Description

n-Side is the founders' former company and direct competitor in clinical supply forecasting and optimization, offering analogous services for clinical trial supply chains. Trialzen's founders (Cédric Druck, Bruno Coppè, Yves Pochet) built n-Side before starting Trialzen, making it the most directly comparable competitor.

TypeBroad incumbent
Description

Medidata, a Dassault Systèmes company, provides a comprehensive clinical trial platform including Rave RTSM and supply management modules. Its broad installed base at top pharma sponsors makes it a key incumbent player in the same customer conversation as Trialzen.

TypeDirect peer
Description

4G Clinical provides randomization and trial supply management (RTSM/IRT) technology, including supply forecasting capabilities, for clinical trials. Trialzen's CEO Cédric Druck previously worked at 4G Clinical, and both companies compete for medical-supply and forecasting budgets at pharma sponsors.

TypeDirect peer
Description

Cenduit, an IQVIA company, is a leading provider of IRT/RTSM and clinical supply management technology for clinical trials. It competes directly with Trialzen's forecasting and supply planning capabilities, particularly for sponsors looking to consolidate supply and IRT on a single platform.

TypeOthers
Description

Catalent is a global CDMO offering clinical supply services and digital supply chain tools for pharma sponsors. Its Tony Street (now SVP Strategy at Trialzen) and Markus Vogt SVP backgrounds at Catalent/ThermoFisher highlight the talent crossover and the overlap in clinical supply planning conversations.

TypeOthers
Description

Almac Group provides clinical trial supply services including packaging, distribution, and supply chain management with proprietary forecasting and optimization software. It is more of a services-led competitor but operates in the same clinical supply planning domain as Trialzen.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Trialzen

Clinical Trial Supply Chain Softwaretrialzen.com

Trialzen is a Belgian SaaS company that develops the Forecast & Planning Solution (FPS), a cloud platform for clinical trial supply chain forecasting, scenario modeling and RTSM/IRT integration, sold via all-inclusive annual subscriptions to pharmaceutical sponsors and delivered through CRO/CMO partners and a Perceptive eClinical alliance.

What Trialzen does

Trialzen SA is a Belgian private SaaS company founded in 2021 by former n-Side executives Cédric Druck (CEO/CTO), Bruno Coppé (Chairman) and Yves Pochet (Scientific Adviser), headquartered in Lasne, Belgium. It develops the Trialzen Forecast & Planning Solution (FPS), a cloud-based software platform for clinical trial supply chain forecasting, scenario modeling and optimization aimed at pharmaceutical sponsors running global clinical trials, with particular emphasis on oncology and advanced therapy trials. The product combines mathematical optimization, stochastic (Monte Carlo) modeling, real-time RTSM/IRT integration, AI-powered automated release plan generation, and a standard API for enterprise dashboards. Its core value proposition addresses the well-documented industry problem that approximately 50% of manufactured clinical trial drug supply is never administered to patients, with the company citing documented client outcomes of 50x ROI, a 20% reduction in site shipments, and per-study savings exceeding $1 million.

Trialzen operates an enterprise sales-led go-to-market with an all-inclusive annual subscription pricing model (no per-feature fees), supplemented by demo and sandbox environments and active participation in industry events such as GCSG, CSForum, COGEurope and CSDG. Distribution is delivered through direct sales to pharmaceutical sponsors and a partner network of CROs, CMOs and supply chain consultants; in April 2026 Trialzen announced a strategic alliance with Perceptive eClinical to launch Perceptive Clinical Intelligence, embedding its forecasting and simulation engine into Perceptive's Clinphone Pro IRT platform. The company maintains ISO 27001-aligned security controls and GDPR compliance, and has shipped four major platform releases since its v1.0.0 launch in April 2024, most recently v1.8.0 in February 2026. No external venture funding rounds, institutional investors, or parent company ownership signals are disclosed in the available sources.

Trialzen firmographics

Firmographics
Name
Trialzen
Legal name
Trialzen SA
Website
https://trialzen.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Trialzen is a Belgian SaaS company that develops the Forecast & Planning Solution (FPS), a cloud platform for clinical trial supply chain forecasting, scenario modeling and RTSM/IRT integration, sold via all-inclusive annual subscriptions to pharmaceutical sponsors and delivered through CRO/CMO partners and a Perceptive eClinical alliance.
Ownership category
akta.pro rank

Trialzen industry classification

Industry
Product category
Clinical Trial Supply Chain Software
NAICS
Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAOAH
Clinical Trial Supply, Logistics & Vendor Management FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Clinical trial forecasting
  • Supply chain optimization
  • Clinical supply planning
  • RTSM integration software
  • Pharmaceutical supply software

Where Trialzen is headquartered

Location

Headquarters

HQ city
Brussels
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Trialzen business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Subscription - Forecast & Planning Solution (FPS): Software-as-a-service subscription model offering access to Trialzen's forecasting and planning capabilities. All-inclusive pricing model with no per-feature fees. Customers can access demos and sandbox environments before purchase.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualAll-inclusive SaaS subscription

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Trialzen product offering

Product offering

Core offering

Trialzen develops and sells a SaaS platform, the Forecast & Planning Solution (FPS), that enables pharmaceutical sponsors to forecast, plan, and optimize the supply chain for clinical trials. The platform uses stochastic modeling and mathematical optimization to reduce clinical drug waste, optimize RTSM/IRT parameters, and run scenario simulations across complex protocol designs including adaptive trials and oncology studies. Customers access the platform via annual all-inclusive subscriptions and can also engage joint consultancy services through the Perceptive Clinical Intelligence alliance with Perceptive eClinical.

Product overview

Trialzen offers a unified product portfolio centered on its Forecast & Planning Solution (FPS), a SaaS platform for clinical trial supply chain management. The core FPS product provides end-to-end forecasting, planning, and optimization capabilities including real-time RTSM/IRT integration, scenario modeling, and automated release planning. Through the Perceptive Clinical Intelligence alliance, Trialzen's simulation engine is embedded within Perceptive eClinical's Clinphone Pro platform to deliver integrated consultancy services spanning the entire clinical trial lifecycle from early supply planning through mid-study forecast adjustments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Trialzen FPS (Forecast & Planning Solution) SaaS platform providing clinical trial supply chain forecasting, planning, and optimization for pharmaceutical sponsors. Enables design of forecasting models per protocol specifications, optimization of supply budgets, alignment of supply chain with trial schedules, and minimization of overage and waste through predictive analytics, scenario modeling, RTSM/IRT integration, and AI-powered automated release planning.
  • Perceptive Clinical Intelligence Technology-enabled clinical supply consultancy service combining Perceptive eClinical's randomization and clinical supply expertise with Trialzen's forecasting and simulation engine, integrated into Perceptive's Clinphone Pro IRT platform. Lets sponsors execute integrated supply planning across the full clinical trial lifecycle, from early supply planning through mid-study forecast adjustments.

Quantifiable outcome

  • 50x ROI (5,000%) for clients
  • +3 more outcomes

Companies that use Trialzen

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Trialzen technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature10 records

Trialzen partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Perceptive eClinicalcoreStrategic or Co-development Partner · 27 April 2026Strategic alliance to launch 'Perceptive Clinical Intelligence' - a technology-enabled clinical supply consultancy service. Combines Perceptive's 30 years of clinical supply expertise and Clinphone Pro IRT platform with Trialzen's advanced forecasting and simulation technologies. Enables sponsors to move from scenario planning to operational action in a single integrated environment. Engagements reportedly generate savings exceeding $1 million per study.
  • COGEuropeminorGTM or Marketing PartnerContent partnership with COGEurope (The PBC Group). Trialzen serves as a content partner for the annual conference, with Cedric Druck presenting and company having visibility at the event.
  • CROs, CMOs, and Supply Chain ConsultantscoreImplementation/ SI/ Consulting PartnerPartner network of contract research organizations, contract manufacturing organizations, and supply chain management consultants who provide expert guidance to sponsors using Trialzen's software.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Trialzen competitors and assessment

Company assessment

Broad incumbents

  • Clario: Clario (formed from the merger of Bioclinica and ERT) delivers clinical trial endpoint technology, imaging, and RTSM/supply chain solutions. It overlaps with Trialzen in clinical supply and trial technology for pharma sponsors and CROs.
  • Oracle Clinical One: Oracle's Clinical One platform offers randomization, supply management, and trial operations as part of a broad life sciences cloud suite. As a large incumbent, it represents a competitive threat via bundling and an integration partner for Trialzen's complementary forecasting layer.
  • Veeva Systems: Veeva Vault CTMS and Vault EDC are enterprise clinical trial platforms used by most large pharma sponsors. While not a pure-play in supply forecasting, Veeva's broad installed base and clinical operations suite make it a key incumbent that could bundle or compete with Trialzen's specialized supply planning.
  • Medidata (Dassault Systèmes): Medidata, a Dassault Systèmes company, provides a comprehensive clinical trial platform including Rave RTSM and supply management modules. Its broad installed base at top pharma sponsors makes it a key incumbent player in the same customer conversation as Trialzen.

Direct peers

  • Signant Health: Signant Health is a clinical trial technology provider offering RTSM/IRT, patient-centric tools, and clinical supply solutions. It directly overlaps with Trialzen's supply forecasting and RTSM integration value proposition and serves the same pharma sponsor customer base.
  • n-Side: n-Side is the founders' former company and direct competitor in clinical supply forecasting and optimization, offering analogous services for clinical trial supply chains. Trialzen's founders (Cédric Druck, Bruno Coppè, Yves Pochet) built n-Side before starting Trialzen, making it the most directly comparable competitor.
  • 4G Clinical: 4G Clinical provides randomization and trial supply management (RTSM/IRT) technology, including supply forecasting capabilities, for clinical trials. Trialzen's CEO Cédric Druck previously worked at 4G Clinical, and both companies compete for medical-supply and forecasting budgets at pharma sponsors.
  • Cenduit (IQVIA): Cenduit, an IQVIA company, is a leading provider of IRT/RTSM and clinical supply management technology for clinical trials. It competes directly with Trialzen's forecasting and supply planning capabilities, particularly for sponsors looking to consolidate supply and IRT on a single platform.

Others

  • Catalent: Catalent is a global CDMO offering clinical supply services and digital supply chain tools for pharma sponsors. Its Tony Street (now SVP Strategy at Trialzen) and Markus Vogt SVP backgrounds at Catalent/ThermoFisher highlight the talent crossover and the overlap in clinical supply planning conversations.
  • Almac Group: Almac Group provides clinical trial supply services including packaging, distribution, and supply chain management with proprietary forecasting and optimization software. It is more of a services-led competitor but operates in the same clinical supply planning domain as Trialzen.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Trialzen social profiles

Digital presence

Trialzen compliance and trust

Trust signal

Compliance2 records

Trialzen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Trialzen leadership team

Management profile

Number of profiles

Profiles10 records

Trialzen funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Trialzen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trialzen

What does Trialzen do?

Trialzen develops and sells a SaaS platform, the Forecast & Planning Solution (FPS), that enables pharmaceutical sponsors to forecast, plan, and optimize the supply chain for clinical trials. The platform uses stochastic modeling and mathematical optimization to reduce clinical drug waste, optimize RTSM/IRT parameters, and run scenario simulations across complex protocol designs including adaptive trials and oncology studies. Customers access the platform via annual all-inclusive subscriptions and can also engage joint consultancy services through the Perceptive Clinical Intelligence alliance with Perceptive eClinical.

Is Trialzen a public or private company?

Trialzen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Trialzen founded?

Trialzen was founded in 2021. It employs 1 to 10 people.

Where is Trialzen based?

Trialzen is headquartered in Brussels, Belgium, in the Europe region.

How does Trialzen make money?

One revenue line is on record: saaS Subscription - Forecast & Planning Solution (FPS).

Who are Trialzen's main competitors?

Broad incumbents on record are Clario, Oracle Clinical One, Veeva Systems and Medidata (Dassault Systèmes). Direct peers are Signant Health, n-Side, 4G Clinical and Cenduit (IQVIA). Others are Catalent and Almac Group.

Does Trialzen have an API?

Yes. Trialzen FPS offers a standard API that enables business intelligence features and super-powerful reports that easily integrate with customer applications and dashboards. The API supports data exchange with RTSM/IRT systems and allows users to import RTSM data or use one-way integration to identify opportunities. Specific endpoints, authentication methods, rate limits, and versioning details are not publicly documented.

What industry is Trialzen in?

Trialzen's product category is Clinical Trial Supply Chain Software. Its primary akta.pro industry code is HLAGAOAH, Clinical Trial Supply, Logistics & Vendor Management FSP. Its NAICS code is 541512 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled consultancy service that combines Perceptive's clinical supply expertise with Trialzen's advanced planning and simulation technologies. The service aims to address industry inefficiency where approximately 50% of clinical finished goods manufactured for trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply. The alliance enables sponsors to access integrated forecasting and supply optimization tools through Perceptive's Clinphone Pro platform, with the companies reporting real-world engagements generating savings exceeding $1 million.ThemalaysianreservePerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that integrates Perceptive's randomization and clinical supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service aims to address industry-wide inefficiency, with benchmarks showing approximately 50% of clinical finished goods manufactured for trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply. The consultancy, built on 30 years of Perceptive's in-house experience, will be fully integrated into Perceptive's Clinphone Pro platform and targets sponsors across oncology, endocrinology, infectious diseases, and emerging areas such as cell and gene therapies.PR NewswirePerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service addresses a significant industry problem, with industry data showing approximately 50% of Clinical Finished Goods manufactured for clinical trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply each year. The alliance enables sponsors to move from scenario planning to operational action in a single integrated environment, with engagements reportedly generating savings exceeding $1 million per study.YahooPerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and clinical supply expertise with Trialzen's advanced planning and analytics technologies. The service aims to help sponsors design, stress test, and manage clinical supply strategies across the entire clinical trial lifecycle, addressing what the companies call a significant industry problem. Industry benchmarks cited indicate approximately 50% of clinical finished goods manufactured for trials are never administered to patients, with the companies claiming real-world engagements have generated savings exceeding $1 million.TrialzenSustainability Trends in the Clinical Trial Supply ChainThe article outlines sustainability trends in the clinical trial supply chain, emphasizing that reducing production, storage, and transport is the most effective way to lower carbon emissions. It highlights strategies such as local sourcing, partnering with eco-friendly logistics providers, and optimizing packaging recycling to minimize environmental impact. The text also promotes Trialzen's forecasting software as a tool for improving efficiency and reducing waste.